OncoCyte Corporation
(OCX)
undefined
undefined%
At close: undefined
2.32
-0.85%
After-hours Dec 13, 2024, 04:00 PM EST
Balance Sheet (Annual)
Get detailed breakdowns of the balance-sheet with total debts,
total investments, and much more.
Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 |
Cash & Equivalents | 9.43M | 19.99M | 35.60M | 7.14M | 22.07M | 8.03M | 7.60M | 10.17M | 8.00M | 257.00K | 101.00K |
Short-Term Investments | - | 433.00K | 904.00K | 675.00K | 379.00K | 428.00K | 760.00K | 2.24M | 2.54M | 3.28M | 4.63M |
Long-Term Investments | - | 1.70M | 1.70M | 13.42M | 10.96M | - | - | - | - | - | -1.57M |
Other Long-Term Assets | 2.16M | 2.07M | 1.96M | 1.94M | 2.21M | 262.00K | 120.00K | 75.00K | - | - | 1.57M |
Receivables | 484.00K | 2.01M | 1.44M | 203.00K | - | - | - | - | - | - | - |
Inventory | - | 2.12M | 304.00K | - | - | - | - | - | - | - | - |
Other Current Assets | 782.00K | 3.10M | 3.85M | 1.21M | 505.00K | 282.00K | 336.00K | 570.00K | 385.00K | 114.00K | 120.00K |
Total Current Assets | 10.70M | 25.54M | 39.14M | 9.23M | 22.96M | 8.64M | 8.53M | 12.70M | 10.93M | 3.65M | 4.85M |
Property-Plant & Equipment | 5.44M | 10.85M | 8.53M | 6.52M | 3.73M | 614.00K | 822.00K | 688.00K | 576.00K | 118.00K | 148.00K |
Goodwill & Intangibles | 56.59M | 61.63M | 109.93M | 24.20M | - | - | 746.00K | 988.00K | 1.23M | 1.47M | 1.71M |
Total Long-Term Assets | 64.19M | 74.56M | 120.42M | 46.19M | 16.90M | 876.00K | 1.69M | 1.75M | 1.81M | 2.71M | 3.44M |
Total Assets | 74.89M | 100.09M | 159.56M | 55.42M | 39.86M | 9.52M | 10.22M | 14.45M | 12.73M | 6.36M | 8.29M |
Account Payables | 953.00K | 1.25M | 1.81M | 432.00K | 469.00K | 166.00K | 175.00K | 422.00K | 285.00K | 144.00K | 103.00K |
Deferred Revenue | - | - | - | 5.15M | - | - | - | - | -847.00K | - | - |
Short-Term Debt | 1.33M | 1.63M | 2.95M | 3.23M | 1.58M | 1.57M | 1.48M | 404.00K | - | 5.89M | 2.96M |
Other Current Liabilities | 4.91M | 9.22M | 9.36M | 5.33M | 2.39M | 3.83M | 2.80M | 3.45M | 2.03M | 1.40M | 1.61M |
Total Current Liabilities | 7.19M | 12.11M | 14.12M | 9.00M | 4.44M | 5.56M | 4.45M | 4.28M | 2.31M | 7.43M | 4.67M |
Long-Term Debt | 2.20M | 2.73M | 3.54M | 5.82M | 4.58M | 534.00K | 1.36M | 310.00K | - | - | - |
Other Long-Term Liabilities | 39.90M | 50.96M | 76.68M | 7.12M | - | - | - | - | - | - | - |
Total Long-Term Liabilities | 42.10M | 53.69M | 80.23M | 12.94M | 4.58M | 534.00K | 1.36M | 310.00K | - | - | - |
Total Liabilities | 49.30M | 65.80M | 94.35M | 21.94M | 9.02M | 6.09M | 5.81M | 4.58M | 2.31M | 7.43M | 4.67M |
Total Debt | 2.87M | 3.54M | 5.68M | 8.63M | 5.94M | 1.72M | 2.50M | 512.00K | 847.00K | 5.89M | 2.96M |
Common Stock | 310.30M | 294.93M | 252.95M | 157.16M | 124.58M | 74.74M | 59.97M | 45.82M | 34.90M | 15.15M | 15.40M |
Retained Earnings | -289.88M | -260.68M | -187.77M | -123.68M | -93.75M | -71.32M | -54.68M | -35.30M | -24.13M | -15.40M | -10.41M |
Comprehensive Income | 49.00K | 39.00K | 37.00K | 0.00 | - | - | -888.00K | -654.00K | -350.00K | -822.00K | -1.37M |
Shareholders Equity | 25.59M | 34.29M | 65.22M | 33.48M | 30.84M | 3.42M | 4.40M | 9.86M | 10.42M | -1.07M | 3.62M |
Total Investments | 1.70M | 433.00K | 904.00K | 14.09M | 11.34M | 428.00K | 760.00K | 2.24M | 2.54M | 3.28M | 4.63M |